Walter Greenleaf, PhD is a research neuroscientist and medical product developer working at Stanford University.
Walter is known internationally as an early pioneer in digital medicine and virtual environment technology. With over three decades of research and product development experience in the field of medical virtual reality technology, Walter is considered a leading authority in the field.
As a scientist and medical product developer, Walter’s focus has been on computer-supported clinical products, with a specific focus on virtual reality and digital health technology to treat Post-traumatic Stress Disorder, Anxiety Disorders, Traumatic Brain Injury and Stroke, Addictions, Autism, and other difficult problems in behavioral and physical medicine.
He has founded and managed several medical product companies, including Pear Therapeutics, Virtually Better, InWorld Solutions, Cognitive Leap, and Greenleaf Medical.
Walter recently served as the Director for the Mind Division, Stanford Center on Longevity, where his focus was on advancing research on age-related changes in cognition.
He is currently a Distinguished Visiting Scholar at Stanford University’s MediaX Program, a Visiting Scholar at Stanford University’s Virtual Human Interaction Lab, Director of Technology Strategy at the University of Colorado National Mental Health Innovation Center, and Member of the Board of Directors for Brainstorm: The Stanford Laboratory for Brain Health Innovation and Entrepreneurship.
In addition to his research at Stanford University, Walter is Senior Vice President of Strategic & Corporate Affairs to MindMaze and Chief Science Advisor to Pear Therapeutics. He is a VR technology and neuroscience advisor to several early-stage medical product companies, and is a co-founder of Cognitive Leap.
[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.